Advanced T and N stages significantly worsen survival in stage IV colorectal cancer, highlighting the need for careful patient stratification. 5-year cancer-specific survival (CSS) is just 20.7%, dropping to 17.4% for T4 and 14.5% for N2. Higher T and N stages independently increase mortality risk, with T4 (HR: 1.33) and N1/N2 (HR: 1.27 and 1.59) […]
Category: General Surgery
Cost Savings with Enhanced Recovery in Colorectal Surgery
Colorectal enhanced recovery after surgery (ERAS) significantly reduces costs and complications compared to conventional care. ERAS leads to a median cost reduction of AUD 2010 per patient (AUD 20,719 vs. AUD 22,729, p=0.008). Patients on ERAS had a shorter median length of stay (5 vs. 6 days, p<0.001) and lower overall complication rates (26.42% vs. […]
New AI Model Predicts Cardiac Risks in Surgery
A new deep learning model predicts postoperative cardiac events after noncardiac surgery with high accuracy, improving patient safety. The model showed an AUROC of 0.902 for 30-day major adverse cardiac and cerebrovascular events (MACCE), outperforming traditional methods. Only 0.6% of 165,577 patients experienced MACCE, indicating the model’s focus on high-risk patients may enhance targeting for […]
Machine learning predicts complications in acute cholecystitis
Machine learning tools can now help surgeons assess the risk of postoperative complications in acute calculous cholecystitis patients. Cholesurgrisk I achieved an AUC-ROC of 0.8456, while Cholesurgrisk II, which includes intraoperative data, improved this to 0.8903. A web-based version of Cholesurgrisk I offers real-time, patient-specific risk estimates. Integrating these models into practice could enhance preoperative […]
Virtual Scale Endoscopy Outperforms Traditional Polyp Measurement
Virtual Scale Endoscopy (VSE) significantly enhances accuracy in colorectal polyp size measurement, improving surgical decisions and patient outcomes. VSE improved measurement accuracy by 14.5% compared to visual assessment. Reduced total misclassifications from 73.6% to 54.3% with VSE. This suggests VSE could be crucial for better polypectomy and surveillance decisions. VSE also minimized overestimation rates from […]
Guidelines Favor taTME Over Laparoscopic Techniques for Rectal Cancer
taTME offers a preferred option for treating low- and selected mid-rectal cancers in appropriate surgical settings. Strong recommendation for taTME over laparoscopic TME (latme) for sphincter-preserving cases. High-risk patients, especially males with BMI > 30, may benefit most from this approach. Surgeons should consider expertise and high-volume centers when making treatment decisions. Shared decision-making with […]
Efficacy of Extended D2 Lymphadenectomy in Gastric Cancer
Extended D2 lymphadenectomy (D2+) improves outcomes in specific gastric cancer cases. Metastatic rates are 8% for stations 12b/12p and 13, and 7% for 14v, with therapeutic value indices (TVI) of 2.6, 2.4, and 3.9, respectively. Patients with duodenal invasion show significantly higher TVIs: 3.9 (12b/12p), 3.8 (13), and 9.0 (14v) compared to those without. Consider […]
Minimally Invasive Surgery Gains Ground in Pancreatic Cancer
Minimally invasive surgery (MIS) is being validated for pancreatic cancer, impacting how surgeons approach patient selection and procedures. 22 out of 28 statements on MIS received over 90% expert agreement, enhancing surgical guidance. The consensus includes recommendations for left pancreatectomy, pancreatoduodenectomy, and total pancreatectomy tailored for cancer. Surgeons can adopt these evidence-based practices to improve […]
Elra Improves Survival in Hepatic Echinococcosis with CTPV
Elra, or ex vivo liver resection and autotransplantation, offers a promising solution for patients with hepatic alveolar echinococcosis facing cavernous transformation of the portal vein. No intraoperative mortality in both treatment groups; 90-day mortality was 16.7%. Long-term survival for CTPV patients undergoing elra was 72.9%, compared to 29.6% for those treated conservatively. The data supports […]
New Criteria for Surgical Resection in Advanced Pancreatic Cancer
Surgeons can now better assess resectability in pancreatic cancer by focusing on specific vascular targets. Introducing a clear definition: “suitable target” vessels determine anatomic resectability, improving clarity in patient selection. Emphasizes the importance of 3D CT imaging and intraoperative assessment of vascular isolation for successful reconstruction. Adopting this approach enhances surgical eligibility evaluations and has […]